白蛋白结合型紫杉醇治疗晚期宫颈癌的效果及安全性

ionofPaclitaxel[J].ClinCancerRes,2002,8(5):1038-1044.[19]曾靖,张蓉,黄曼妮,等.白蛋白结合型紫杉醇联合铂类治疗晚期或复发性妇科肿瘤的临床分析[J].癌症进展,2014,12(4):387-393.[20]GreenMR,ManikhasGM,OrlovS,etal.Abraxane,anovelCremophor-free,albumin-boundparticleformofPaclitaxelforthetreatmentofadvancednon-small-celllungcancer[J].AnnOncol,2006,17(8):1263-1268.[21]vonHoffDD,RamanathanRK,BoradMJ,etal.Gemcitabineplusnab-ancer:aphaseⅠ/Ⅱtrial[J].JClinOncol,2011,29(34):4548-4554.[22]GelderblomH,VerweijJ,NooterK,etal.CremophorEL:thedrawbacksandadvantagesofvehicleselectionfordrugformulation[J].EurJCancer,2001,37(13):1590-1598.[23]tenTijeAJ,VerweijJ,LoosWJ,etal.Pharmaco-logicaleffectsofformulationvehiclesimplicationsforcancerchemotherapy[J].,2003,42(7):665-685.[24]费鹤良,杨庆尧.PSP对癌症病人化/放疗毒性反应的数据统计分析[J].数理统计与管理,2000,19(6):41-44.(收稿日期:2016-01-20本文编辑:任念)